Skip to content

CMC-1 Replacement Arthroplasty Versus Trapeziectomy

CMC-1 Replacement Arthroplasty Versus Trapeziectomy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07583628
Enrollment
1000
Registered
2026-05-13
Start date
2011-01-01
Completion date
2025-12-31
Last updated
2026-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis in the Carpometacarpal (CMC) Joint

Keywords

thumb base, osteoarthritis, PROM, trapeziectomy, joint replacement, CMC-1

Brief summary

Thumb carpometacarpal (CMC-1) osteoarthritis is a common condition causing pain and disability, particularly among middle-aged and older women. When non-operative treatment fails, surgery is indicated. In Sweden, trapeziectomy (TE), with or without tendon-based adjuncts, is the standard procedure and recommended in the National Care Program introduced in 2022. However, total joint arthroplasty (TJA) has gained popularity because of reports of faster recovery and improved early function, although concerns remain regarding complications, durability, and cost. Comparative studies are therefore needed. The aim of this study is to compare patient-reported outcomes after dual-mobility TJA versus TE, with or without tendon-based adjuncts, for CMC-1 osteoarthritis using data from the Swedish Hand Surgery Quality Register (HAKIR). To reduce bias in observational data, the study will emulate a hypothetical randomized target trial. This registry-based cohort study will include adults aged 45 years or older undergoing primary surgery for CMC-1 osteoarthritis. Patients with previous CMC-1 surgery, bilateral procedures, inflammatory joint disease, or extensive missing baseline data will be excluded. Baseline is defined as the date of surgery, and patients will be followed using patient-reported outcome measures collected preoperatively and at 3 and 12 months. The primary outcome is change in pain on load measured with the HQ-8 questionnaire at 12 months. Secondary outcomes include pain at 3 months, low pain levels at 12 months, other HQ-8 domains, QuickDASH score, patient satisfaction, grip and pinch strength, thumb range of motion, time to reoperation, and postoperative complications. Potential confounders will be identified using a directed acyclic graph (DAG). Measured confounders include age, sex, surgical centre, calendar year, baseline pain, baseline function, and smoking. Unmeasured factors such as surgeon preference, patient preference, and disease severity not captured in the registry may still cause residual confounding. Primary analyses will use linear mixed-effects regression to compare adjusted mean pain outcomes between groups at 12 months while accounting for clustering by patient and centre. Secondary outcomes will be analysed using ordinal logistic regression, Cox proportional hazards regression, and logistic regression. Missing data will be handled using multiple imputation, and sensitivity analyses using inverse probability weighting will assess the impact of reoperations and selection bias

Interventions

None listed

Sponsors

Karolinska Institutet
Lead SponsorOTHER
Erasmus Medical Center
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

adults aged ≥45 years with a diagnosis of CMC-1 osteoarthritis (ICD-10 code M18) who have failed non-operative treatment and are scheduled for primary CMC-1 surgery.

Exclusion criteria

* Bilateral CMC-1 surgery or other simultaneous hand interventions * Previous CMC-1 surgery on the affected hand * Inflammatory joint disease affecting the hands (e.g., rheumatoid arthritis, systemic lupus erythematosus) * 30% missing baseline (preoperative) variables

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline to 12 months in pain on load motion measured with the HAKIR questionnaire.Baseline and 12 months postoperativelyPain on load motion assessed using the HQ-8 patient-reported outcome questionnaire. Responses are reported on an 11-point numerical rating scale ranging from 0 (no symptoms or discomfort) to 100 (worst imaginable symptoms or discomfort) in increments of 10.

Secondary

MeasureTime frameDescription
Change from baseline to 12 months in pain on unloaded motion measured with the HAKIR questionnaireBaseline and 12 months after surgeryPain on unloaded motion assessed using the HQ-8 patient-reported outcome questionnaire. Responses are reported on an 11-point numerical rating scale ranging from 0 (no symptoms or discomfort) to 100 (worst imaginable symptoms or discomfort) in increments of 10.
Change from baseline to 12 months in pain at rest measured with the HQ-8 questionnaireBaseline and 12 months postoperativelyPain at rest assessed using the HQ-8 patient-reported outcome questionnaire. Responses are reported on an 11-point numerical rating scale ranging from 0 (no symptoms or discomfort) to 100 (worst imaginable symptoms or discomfort) in increments of 10.
Change from baseline to 12 months in stiffness measured with the HQ-8 questionnaireBaseline and 12 months postoperativelyStiffness assessed using the HQ-8 patient-reported outcome questionnaire. Responses are reported on an 11-point numerical rating scale ranging from 0 (no symptoms or discomfort) to 100 (worst imaginable symptoms or discomfort) in increments of 10.
Change from baseline to 12 months in weakness measured with the HQ-8 questionnaireBaseline and 12 months postoperativelyWeakness assessed using the HQ-8 patient-reported outcome questionnaire. Responses are reported on an 11-point numerical rating scale ranging from 0 (no symptoms or discomfort) to 100 (worst imaginable symptoms or discomfort) in increments of 10.
Change from baseline to 12 months in activities of daily living measured with the HQ-8 questionnaireBaseline and 12 months postoperativelyActivities of daily living assessed using the HQ-8 patient-reported outcome questionnaire. Responses are reported on an 11-point numerical rating scale ranging from 0 (no symptoms or discomfort) to 100 (worst imaginable symptoms or discomfort) in increments of 10.
Change from baseline to 12 months in Quick Disabilities of Arm, Shoulder and Hand Questionnaire (Quick DASH)Baseline and 12 months postoperativelyUpper extremity disability and symptoms assessed using the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire. Scores range from 0 to 100, where higher scores indicate greater disability and worse upper extremity function.
Change in key pinch strengthBaseline and 12 months postoperativelykg
Change in grip strengthBaseline and 12 months postoperativelyjamar (kg)
Change in thumb radial abductionBaseline and 12 months postoperativelyradial abduction (degrees)
Change in thumb plamar abductionFrom preoperatively to 12 months postoperativelypalmar abduction (degrees)
Time to first reoperation* of the index handprimary horizon: 12 months; secondary: maximum available follow-up
Risk of any (non-reoperation) complication within 12 monthswithin 12 months after surgeryoccurrence of any registered postoperative complication of the index hand recorded in HAKIR

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 14, 2026